Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study. Journal of Analytical Oncology, [S. l.], v. 2, n. 3, p.  128–134, 2013. DOI: 10.6000/1927-7229.2013.02.03.1. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/77. Acesso em: 20 oct. 2025.